'Treating Alzheimer’s patients as early as possible — when symptoms and brain pathology are mildest — provides a better chance of slowing cognitive decline, a large study of an experimental #Alzheimer’s drug presented Monday suggests'

https://www.nytimes.com/2023/07/17/health/alzheimers-drug-donanemab.html?action=click&module=Well&pgtype=Homepage&section=Health